| Literature DB >> 33007906 |
Thomas Chalklen1, Qingshen Jing1, Sohini Kar-Narayan1.
Abstract
Biosensors are powerful analytical tools for biology and biomedicine, with applications ranging from drug discovery to medical diagnostics, food safety, and agricultural and environmental monitoring. Typically, biological recognition receptors, such as enzymes, antibodies, and nucleic acids, are immobilized on a surface, and used to interact with one or more specific analytes to produce a physical or chemical change, which can be captured and converted to an optical or electrical signal by a transducer. However, many existing biosensing methods rely on chemical, electrochemical and optical methods of identification and detection of specific targets, and are often: complex, expensive, time consuming, suffer from a lack of portability, or may require centralised testing by qualified personnel. Given the general dependence of most optical and electrochemical techniques on labelling molecules, this review will instead focus on mechanical and electrical detection techniques that can provide information on a broad range of species without the requirement of labelling. These techniques are often able to provide data in real time, with good temporal sensitivity. This review will cover the advances in the development of mechanical and electrical biosensors, highlighting the challenges and opportunities therein.Entities:
Keywords: MEMS biosensor; biosensors; electrical biosensor; mechanical biosensor
Mesh:
Year: 2020 PMID: 33007906 PMCID: PMC7584018 DOI: 10.3390/s20195605
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1Schematic diagram representing biosensor applications and fields. (a) Biosensors categorised into different fields based on detection and signal transduction methods; mechanical and electrical fields are highlighted as the area of study for this review. (b) Biosensor applications of chosen fields, showing suitable biosensors for detection of different analytes, including: (i) antibody detection, (ii) small molecule detection, (iii) intravascular detection, (iv) full body measurements, (v) DNA detection, (vi) cell measurements.
Figure 2Schematic of the cantilever-based measurement system proposed by Boisen and Thundat. The bending of the cantilever caused by the attachment of the molecules changes the resistance of the built-in resistor. Two adjacent units, one of which serves as reference, are measured simultaneously and only the difference between signals is recorded. Reprinted with permission from [35]. Copyright © 2009 Elsevier Ltd.
Figure 3Schematic of the attachment and bending caused by target molecules on the probe on an embedded-metal–oxide–semiconductor field-effect transistor (MOSFET), proposed by Shekhawat. The silicon nitride cantilever acts as reference. The drain current of the MOSFET will change under local stress due to the conductivity modulation of the channel underneath the gate, hence the targeted molecules being sensed. Reprinted with permission from [36]. Copyright © 2006, American Association for the Advancement of Science.
Figure 4A schematic of cantilever type biosensor that can detect different biological components. Spots A-D indicate different receptors while particles were assumed to be attracted at spot C, as an example. Reprinted from [54] under CC BY 4.0. (https://creativecommons.org/licenses/by/4.0/).
Figure 5Schematic mechanism of photoacoustic effect and imaging. Tissue constituents absorb pulsed near infrared laser and undergo thermoelastic expansions, which generate ultrasound signals that can be then detected by ultrasound detector. Reprinted from [60] under CC BY 4.0. (https://creativecommons.org/licenses/by/4.0/).
Figure 6A mechanical scanning image showing carbon-fibre network. (Scale bar: 500 μm) Reprinted from [55] under CC BY 4.0. (https://creativecommons.org/licenses/by/4.0/).
Figure 7Schematic view of the MEMS hydrophone with bionic structure, proposed by Zhang. Reprinted from [90] under CC BY 4.0. (https://creativecommons.org/licenses/by/4.0/).
Figure 8Piezoelectric cell force sensor. (a) Schematic of a cell force sensing device based on Poly-l-lactic acid (PLLA) piezoelectric nanostructures. (b) SEM image showing cellular interaction with PLLA nanotubes. Reprinted with permission from [107] (https://pubs.acs.org/doi/10.1021/acsabm.0c00012), Copyright © 2020 American Chemical Society (further permissions related to the material excerpted should be directed to the ACS).
Figure 9A cross-section structure of thin-film bulk acoustic wave piezoelectric resonator for microbalance chemical sensing. Reprinted with permission from [119]. Copyright © 2005 American Institute of Physics.
Figure 10Illustration of the working principle of the hybrid biosensor developed by Liu. that combined QCM with ECIS. Reprinted from [125] under CC BY-NC-SA 3.0 (https://creativecommons.org/licenses/by-nc-sa/3.0/).
Figure 11Schematic structure of the heart rate sensor that contains an MEMS pressure sensing elements. The capacitance of the elements changes according to the pressure change caused by the deformation of the diaphragm. Reprinted from [133] under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/).
Figure 12Representations of the experimental process of using spinning disk for blood component separation. (A) Spinning process including: 1. putting medium (Ficoll) into the disc sections. 2. spinning the medium. 3. putting whole blood sample into the disc sections. 4. spinning the blood sample. (B) Illustration of blood components distributions after the spinning. (C) Image captured for process via a computer. The achievement of automatic counting is assisted by the counting grid etched on the outer surface of the disc sections. Reprinted with permission from [138]. Copyright © 2019 Elsevier B.V.
Figure 13Device using dielectrophoretic transportation with cell trapping in cavity. (a) Electrode area where droplet is placed. (b) Cell is transported toward the cavity electrode. (c–f) Single cells are captured in cavity electrode for impedance measurement. Reprinted with permission from [170]. Copyright © 2013 Elsevier B.V.
Figure 14(a) Schematic view of a digital microfluidic device for cell culture and impedance measuring. The device contains 6 patterned cell-culture sites named virtual microwell and 66 electrodes. (b) Side view of the device. Reprinted with permission from [146]. Copyright © 2012 Elsevier B.V.
Figure 15A schematic microelectrode array for cell counting. Reprinted with permission from [143]. Copyright © 2012 Elsevier B.V.
Figure 16Directions of cell movement based on dielectrophoresis interactions. (a,b) show the responses of positive/negative dielectrophoresis. Reprinted with permission from [186]. Copyright © 2005 Elsevier B.V.
Figure 17Illustration of the working mechanism for a frequency hopping based dielectrophoresis cell filter over interdigitated electrodes, proposed by Modarres. A higher applied frequency traps all sized particles trying to pass over the electrodes while various lower frequency (a)/(b) release different sized particles to achieve size filtering. Reprinted with permission from [211]. Copyright © 2019 Elsevier B.V.
Figure 18The operation mechanism of an FET biosensor. Reprinted with permission from [214]. Copyright© 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Figure 19(a) Schematics of the fabrication procedure to integrate immunoglobulin G (IgG)/polypyrrole nanotube FET-type biosensor. (b) S and D represent source and drain electrodes, while the gate electrode was immersed in the buffer as a liquid-ion gate. Reprinted from [233] under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/).
Summary and comparison of electrical and mechanical biosensors against other leading biosensor techniques.
| Field | Ref. | Detection Limit/fg mL−1 | Analyte | Bioprobe | Analytical Surface | Notes | Advantages | Disadvantages |
|---|---|---|---|---|---|---|---|---|
| Microcantilever | [ | 50 | Prostate Specific Antigen | Antibody | Silicon | Trampoline shaped resonator, vacuum required | High sensitivity, label free, commercially available, easy fabrication. | Complex preparation, use of lasers and preference for vacuum conditions. |
| [ | 4 | Estradiol hormone | Antibody | Silicon | Array of microcantilevers, optical lever type detection | |||
| [ | 21,000 | Gold Nanoparticle | - | Silicon | Suspended nanochannel resonator, low flow rate (1 pL s−1) | |||
| Photoacoustic | [ | 775,000,000 | ONOO- marked with CyBA | Small molecule | In vivo | Commercial LED Photoacoustic imaging system at 1 cm depth | Non-invasive imaging and detection, real-time measurements, useful for flow cytometry. | Lasers commonly used, bulky, expensive. |
| [ | 0.9 | HF | - | Silicon | Microcantilever transducer | |||
| [ | 150,000 | Malaria infected RBC | - | In vivo | Photoacoustic flow cytometry | |||
| Micropillar | [ | - | HeLa | Fibronectin | Silicon | Gold disk coated silicon pillars, traction force 1 nN LoD | Effective force sensors, could use cells as proxy, could be developed with electrical measurement. | Currently complex image processing, sensitivity needs improvement, not physiological conditions. |
| [ | - | Mouse embryonic fibroblasts | Fibronectin | PDMS | Silicon templated PDMS pillars, traction force 0.1 nN LoD | |||
| [ | - | Water flow | - | Silicon on PZT | Si array embedded in PDMS, water velocity LoD 8.2 µm s−1 | |||
| QCM | [ | 130,000 | C-reactive protein | Antibody | Gold on Quartz | Indirect competitive reaction | Commercially available, cheap, real time measurements, label free. | Sensitivity limited by size constraints; surface functionalisation remains key issue. |
| [ | 50,000,000 | DNA | DNA | Gold on Quartz | Complementary DNA immobilised with sulphur on gold | |||
| [ | 14.3 | Lysozyme | DNA | Gold on Quartz | Biocatalytic precipitation amplified | |||
| SAW | [ | 3,500,000 | Bacterial endotoxin | DNA | Graphene on Quartz | Single layer graphene | Commercially available, real-time measurements, potential for higher sensitivity than QCM, label free. | Surface functionalisation still issue, relatively long preparation. |
| [ | 310,000 | Carcinoembryonic antigen | Antibody | Gold on Quartz | Chemically modified gold, stable over 30 days | |||
| [ | 100,000,000 | E. Coli | Antibody | AlN | Flexible AlN on PEN, for polymer RFID food packaging | |||
| ECIS | [ | 1000 | C-reactive protein | Antibody | Polypyrrole on PS | Conductive coated polystyrene electrospun mat, low cost | Spatial resolution possible, real time response, label free, simple, cheap. | Challenge processing and interpreting data, difficult to measure single cells. |
| [ | 3,300,000 | Okadaic acid | HeLa Cells | HeLa cells on Gold | Cells used as proxy for toxin | |||
| [ | 200 | E. Coli | Antibody | Gold | Functionalised with self-assembled monolayer template | |||
| Dielectrophoresis | [ | 1000 | Cardiac troponin I | Antibody | Carbon nanotube | Dielectrophoretic enhancement, impedance measurement | Can purify molecules of interest, non-invasive, commercially available, easy fabrication. | By itself not sensitive, can cause cell death, affected by environmental factors. |
| [ | 3.4 | Prostate Specific Antigen | Antibody | Silicon nanowire | Dielectrophoretic enhancement, impedance measurement | |||
| [ | 27,000,000 | Trypanosome | - | Gold on Glass | Spiral electrodes concentrates analyte, manual visual count | |||
| FET | [ | 23 | Prostate Specific Antigen | Antibody | Silicon nanowire | Surface modified with Gold nanoparticles | Extremely sensitive, commercial technology, real time measurements, simple interpretation. | Sensitive to environment. |
| [ | 1 | Micro RNA | DNA | Silicon nanowire | PNA functionalised surface | |||
| [ | 3.2 | DNA | DNA | Carbon nanotube | Single strand DNA functionalised surface | |||
| SPR | [ | 10,000 | Cardiac troponin T | Antibody | Gold | Modified gold with carboxymethyldextran hydrogel | Wide range of analytes, small sample volumes. | Dependent on surface functionalisation, requires knowledge of reaction mechanism, slow. |
| [ | 1,500,000 | C-reactive protein | E. Coli | Gold | Autodisplaying E. Coli as proxy | |||
| [ | 68,000 | Cardiac troponin I | Antibody | Gold | Chemically modified gold | |||
| Electrochemical | [ | 72,000,000 | Glucose | - | ZnO nanorods | CuO nanoparticle modified | Simple interpretation, commercially available, well characterised. | Increasingly small gains, complex fabrication required for high sensitivity. |
| [ | 55 | DNA | DNA | Gold nanorods | On Graphene Oxide base | |||
| [ | 5,400,000 | Glucose | - | Nanocomposite | Graphene, Ni and polyvinyl pyroldine nanocomposite |